NEW YORK, Dec. 12 - Cepheid granted Baltimore-based Environmental Technologies Group a sublicense to key patents for development of rapid, hand-held DNA analysis systems for bioagent detection, the company said on Wednesday.
The sublicense is worldwide and non-exclusive, and grants ETG rights to patented component designs for performing and monitoring analytical reactions, such as PCR, used in DNA detection on a hand-held device using battery power. Cepheid retains rights to commercialize hand-held systems for all other DNA-testing applications, including environmental testing and veterinary diagnostics, according to the company.
Cepheid and ETG have a US Department of Defense contract to deliver hand-held biological detection devices.
Cepheid, based in
"Cepheid views this new agreement as a continuation of our partnership with ETG in the area of bioagent detection for both military and homeland security applications," Tom Gutshall, CEO of Cepheid, said in a statement. "This agreement leverages the combined strengths of both companies across a range of markets, and presents a valuable opportunity for Cepheid to apply our core patents to development of a hand-held device."
Cepheid holds the exclusive license to these analytical reaction design patents from the